Table 2.
Inhibitor | Domain | Kinetics | Group | HumanTiter (BU/mg) | Porcine Titer (BU/mg) | Ovine Titer (BU/mg) |
---|---|---|---|---|---|---|
4A4 | A2 | I | A | 25,500 | < 8 | < 8 |
413 | A2 | I | A | 61,000 | < 1 | < 1 |
4F4 | A2 | I | B | 330 | < 1 | < 1 |
B25 | A2 | I | C | 18 | < 4 | < 1 |
1D4 | A2 | I | E | 51,000 | 5 | 6 |
G48 | A2 | II | C | * | * | * |
2–54 | A2 | II | D | **** | * | * |
3E6 | C2 | I | A | 11 | < 1 | < 4 |
I109 | C2 | I | AB | 3,100 | < 1 | < 1 |
D102 | C2 | I | B | 8,600 | 10 | 5 |
3D12 | C2 | I | B | 3,800 | < 1 | < 1 |
I14 | C2 | II | BC | **** | * | ** |
B75 | C2 | II | BC | * | * | * |
3G6 | C2 | II | BC | **** | * | * |
G99 | C2 | II | BC | **** | * | * |
2–77 | C2 | II | BC | **** | * | * |
I55 | C2 | II | BC | **** | * | * |
ESH-8 | C2 | II | C | **** | * | * |
2–117 | C2 | II | C | * | * | * |
0–100 BU/mg;
100–1,000 BU/mg;
1,000–10,000 BU/mg;
> 10,000 BU/mg